News
December 10, 2024
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
November 25, 2024
OnKure Announces New Date for Upcoming Investor Call
November 5, 2024
OnKure to Present at the Stifel 2024 Healthcare Conference
- View All News